Pharmaron Beijing Co., Ltd. (SHE:300759)
China · Delayed Price · Currency is CNY 22.09
+0.10 (0.45%)
Jun 17, 2026, 2:25 PM CST
Pharmaron Beijing Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Pharmaron Beijing stock has a consensus rating of "Buy" and an average price target of ¥36.33. The average 1-year stock price forecast is 64.46% higher than the current stock price, while the lowest is ¥23.80 (+7.74%) and the highest is ¥40.00 (+81.08%).
Price Target: ¥36.33 (+64.46%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pharmaron Beijing stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 8 | 8 | 7 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 13 | 14 | 13 | 12 |
Financial Forecast
Revenue This Year
16.35B
from 14.10B
Increased by 15.99%
Revenue Next Year
18.84B
from 16.35B
Increased by 15.26%
EPS This Year
1.18
from 0.87
Increased by 36.08%
EPS Next Year
1.37
from 1.18
Increased by 16.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.5B | ||
| Avg | 16.3B | ||
| Low | 16.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.1% | ||
| Avg | 16.0% | ||
| Low | 14.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.22 | ||
| Avg | 1.18 | ||
| Low | 1.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.5% | ||
| Avg | 36.1% | ||
| Low | 33.0% |